Globus Medical GMED Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's stock issuance proceeds?
- Globus Medical (GMED) reported stock issuance proceeds of $25.96M in Q1 2026.
- How has Globus Medical's stock issuance proceeds changed year-over-year?
- Globus Medical's stock issuance proceeds increased by 131.3% year-over-year, from $11.22M to $25.96M.
- What is the long-term trend for Globus Medical's stock issuance proceeds?
- Over 4 years (2021 to 2025), Globus Medical's stock issuance proceeds has grown at a 9.0% compound annual growth rate (CAGR), from $63.5M to $89.76M.
- What does stock issuance proceeds mean?
- Cash received from selling company shares.
- How do you interpret stock issuance proceeds?
- Higher proceeds from options indicate employee participation in equity plans, while proceeds from offerings indicate capital raising activities.
- How does stock issuance proceeds compare across companies?
- Standard across all public companies with equity-based compensation.